Wellington Management Group
REGN icon

Wellington Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$37.4M Buy
71,155
+53,741
+309% +$28.2M 0.01% 767
2025
Q1
$11M Sell
17,414
-131,415
-88% -$83.3M ﹤0.01% 1173
2024
Q4
$106M Sell
148,829
-291,780
-66% -$208M 0.02% 520
2024
Q3
$463M Sell
440,609
-621,182
-59% -$653M 0.08% 213
2024
Q2
$1.12B Sell
1,061,791
-31,184
-3% -$32.8M 0.2% 122
2024
Q1
$1.05B Sell
1,092,975
-9,115
-0.8% -$8.77M 0.19% 137
2023
Q4
$968M Sell
1,102,090
-404,795
-27% -$356M 0.18% 135
2023
Q3
$1.24B Sell
1,506,885
-162,047
-10% -$133M 0.25% 102
2023
Q2
$1.2B Sell
1,668,932
-98,987
-6% -$71.1M 0.23% 105
2023
Q1
$1.45B Sell
1,767,919
-648,328
-27% -$533M 0.29% 91
2022
Q4
$1.74B Sell
2,416,247
-27,042
-1% -$19.5M 0.35% 69
2022
Q3
$1.68B Buy
2,443,289
+60,342
+3% +$41.6M 0.36% 71
2022
Q2
$1.41B Sell
2,382,947
-507,256
-18% -$300M 0.28% 85
2022
Q1
$2.02B Sell
2,890,203
-244,572
-8% -$171M 0.35% 73
2021
Q4
$1.98B Sell
3,134,775
-233,290
-7% -$147M 0.32% 75
2021
Q3
$2.04B Sell
3,368,065
-689,317
-17% -$417M 0.35% 74
2021
Q2
$2.27B Buy
4,057,382
+181,002
+5% +$101M 0.38% 70
2021
Q1
$1.83B Buy
3,876,380
+245,858
+7% +$116M 0.32% 78
2020
Q4
$1.75B Buy
3,630,522
+151,995
+4% +$73.4M 0.32% 77
2020
Q3
$1.95B Sell
3,478,527
-185,341
-5% -$104M 0.4% 66
2020
Q2
$2.28B Buy
3,663,868
+1,607,109
+78% +$1B 0.51% 49
2020
Q1
$1B Sell
2,056,759
-193,156
-9% -$94.3M 0.27% 88
2019
Q4
$845M Buy
2,249,915
+481,959
+27% +$181M 0.18% 132
2019
Q3
$490M Sell
1,767,956
-11,331
-0.6% -$3.14M 0.11% 194
2019
Q2
$557M Sell
1,779,287
-337,435
-16% -$106M 0.12% 185
2019
Q1
$869M Sell
2,116,722
-890,904
-30% -$366M 0.2% 127
2018
Q4
$1.12B Sell
3,007,626
-1,068,785
-26% -$399M 0.28% 91
2018
Q3
$1.65B Sell
4,076,411
-302,068
-7% -$122M 0.35% 72
2018
Q2
$1.51B Buy
4,378,479
+56,011
+1% +$19.3M 0.34% 80
2018
Q1
$1.49B Sell
4,322,468
-5,221
-0.1% -$1.8M 0.34% 77
2017
Q4
$1.63B Sell
4,327,689
-521,145
-11% -$196M 0.36% 74
2017
Q3
$2.17B Sell
4,848,834
-692,351
-12% -$310M 0.5% 51
2017
Q2
$2.72B Sell
5,541,185
-594,374
-10% -$292M 0.64% 37
2017
Q1
$2.38B Buy
6,135,559
+446,850
+8% +$173M 0.57% 41
2016
Q4
$2.09B Sell
5,688,709
-1,270,123
-18% -$466M 0.52% 44
2016
Q3
$2.8B Buy
6,958,832
+661,614
+11% +$266M 0.7% 29
2016
Q2
$2.2B Buy
6,297,218
+84,824
+1% +$29.6M 0.57% 42
2016
Q1
$2.24B Buy
6,212,394
+1,426,801
+30% +$514M 0.59% 38
2015
Q4
$2.6B Sell
4,785,593
-239,461
-5% -$130M 0.68% 33
2015
Q3
$2.34B Sell
5,025,054
-479,494
-9% -$223M 0.65% 32
2015
Q2
$2.81B Sell
5,504,548
-286,790
-5% -$146M 0.72% 27
2015
Q1
$2.61B Sell
5,791,338
-88,860
-2% -$40.1M 0.67% 31
2014
Q4
$2.41B Buy
5,880,198
+43,858
+0.8% +$18M 0.64% 32
2014
Q3
$2.1B Buy
5,836,340
+166,994
+3% +$60.2M 0.58% 34
2014
Q2
$1.6B Buy
5,669,346
+1,191,241
+27% +$336M 0.43% 56
2014
Q1
$1.34B Buy
4,478,105
+152,098
+4% +$45.7M 0.37% 62
2013
Q4
$1.19B Buy
4,326,007
+7,251
+0.2% +$2M 0.34% 69
2013
Q3
$1.35B Sell
4,318,756
-130,700
-3% -$40.9M 0.42% 57
2013
Q2
$1B Buy
+4,449,456
New +$1B 0.33% 70